Lee BioSolutions Inc, an international manufacturer, producer and supplier of high purity proteins and antigens announces that it will supply high purity Hemoglobin A1C to the Diabetes Market. Hemoglobin A1C is isolated from Red Blood cells and is used as an indicator of blood glucose in a diabetic patient. The A1C test is an important test in the diagnosis and management of diabetes.

According to the World Health Organization there are over 350 million people who have diabetes worldwide. Current news reports say that 50% of individuals living in the United States are either pre-diabetic or diabetic.

Lee Biosolutions recognizes the growing diabetes market and is committed in providing the highest quality Hemoglobin A1C protein and is working closely with major diagnostic companies to meet demand of this highly desirable indicator. . In addition to isolating A1C from red blood cells, Lee Biosolutions is also providing prediabetic, diabetic Type 1 and diabetic Type 2 urine from donors.

“Lee Biosolutions is on the forefront of Diabetes research by supplying highly purified markers such as Hemoglobin A1C,“ said Burton Lee, President of Lee Biosolutions . “ What is unique about this test is that patients do not need to fast as with the common fasting plasma glucose test. Since HbA1C builds up in red blood cells throughout the lifetime of diabetic patients, its levels represent an excellent record of blood glucose levels over the previous 2-3 months. We are happy to be a part of early diagnosis of a disease that is so common but is taken so much for granted.“

About Lee BioSolutions, Inc.
Lee BioSolutions is an international producer and supplier of high purity finished human proteins. Headquartered in St. Louis and founded in 2002, the biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes the raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include Low Denisity Lipoprotein (LDL),High Denisity Lipoprotein(HDL), Myeloperoxidase, C-Reactive Protein, CkMB and Troponin, The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee BioSolutions visit http://www.LeeBio.com or call 314-968-1091.

Saint Louis, MO Lee BioSolutions Inc, is an international manufacturer, producer and supplier of high purity biomarkers used in the prediction, prevention and management of cardiovascular diseases known as CVD. The St. Louis-based biotechnology health care firm has developed a unique proprietary process to effectively and efficiently purify Biochemical Biomarkers such as Low Density Lipoprotein (LDL) and High Density Lipoprotein(HDL) from Human Plasma used by manufacturers of lipid profile blood tests. As a result, Lee is now is a preferred producer for clinical researchers and diagnostic companies around the world to supply these critical components .

According to the World Health Organization located in Switzerland, 30% of all global deaths are attributed to CVD which encompasses a group of disorders of the heart and blood vessel. These disorders include coronary heart disease, cerebrovascular disease, peripheral arterial disease , rheumatic heart disease, congenital heart disease and deep vein thrombosis and pulmonary embolism.
Lee’s cholesterol products, Low Density Lipoprotein and High Density Lipoproteins are carefully isolated from human plasma and are supplied to international diagnostic companies to produce quality diagnostic tests for Cholesterol ,HDL,LDL and Triglycerides. As a result, Lee has hired additional scientists to meet global market demand.

Burton Lee , President of Lee Biosolutions says, Cholesterol itself is not a problem but its when you have high levels of cholesterol and LDL is when you run into trouble. Too many people think of cholesterol as something bad but in actuality you need cholesterol for the synthesis of vitamin D and hormones in your body. Cholesterol is needed to help with fat absorption molecules by converting to bile in your digestive tract. One way to manage your health is to get a lipid profile test and that’s where we come in. We are the supplier of these analytes that go into these blood tests. We also see another promising set of biomarkers that will be very popular for heart disease management and they are Pro-BNP and NT-proBNP which we are offering . “

About Lee BioSolutions, Inc.
Lee BioSolutions is an international producer and supplier of high purity finished human proteins. Headquartered in St. Louis and founded in 2002, the biotechnology healthcare firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes the raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include Low Denisity Lipoprotein(LDL),High Density Lipoprotein(HDL), CkMB and Troponin, Myeloperoxidase, C-Reactive Protein and NT-proBNP, The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee BioSolutions visit http://www.LeeBio.com or call 314-968-1091.

Lee BioSolutions Supplies D-Dimer , Key Component of Deep Vein Thrombosis Detection and Pulminary Embolism

ST. LOUIS , MO Lee BioSolutions, an international manufacturer, producer and supplier of high purity proteins and antigens announces an increased in supply of D-Dimer protein. The St. Louis-based biotechnology firm recently developed a proprietary process to effectively and efficiently purify the marker for Deep Vein Thrombosis and Pulmonary Embolism. As a result, Lee is supplying bulk quantities of this critical components for thrombosis tests to major manufacturers for early detection of blood clots to prevent DVT.

According to the Centers of Disease and Control, CDC, , Deep Vein Thrombosis and Pulmonary Embolism affects up to 600,000 individuals in the US alone each and every year . What happens in the most serious of cases is Deep Vein Thrombosis or DVT when part of a blood clot breaks off in the leg and travels through the bloodstream to the lungs causing a blockage called pulmonary embolism. DVT/PLE shows no preference to age, gender or ethnicity and is one of those disorders that is repeatedly underdiagnosed causing serious illness, disability and even death. In fact 10% of individuals diagnosed with DVT will die within the first month of diagnosis because they were not treated early enough. With risk factors such as aging population , more sedentary habits among individuals and obesity , this disorder is becoming an important and growing public health concern.

Lee’s new D-Dimer production capabilities enables international diagnostics companies to quickly manufacture serum D-Dimer tests, which are affordable and easy to administer. Lee has scaled up production to meet global market demand.

“Lee Biosolutions is on the forefront of Coagulation disorders and Deep Vein Thrombosis research by supplying a highly purified clot dissolving substance call D-Dimer from human serum “ said Burton Lee, President of Lee Biosolutions . “ D-Dimer test is used for detecting increased D dimer in your blood is most useful for ruling out deep vein thrombosis or for identifying people at risk of recurrence. “

Lee Biosolutions is also involved with early detection of Diabetes with our new HbA1c and detection of Chronic Kidney Disease with cystatin C protein . We are all about saving lives with early detection of clinical diseases.

About Lee BioSolutions, Inc.
Lee BioSolutions is an international producer and supplier of high purity human, animal and recombinant proteins, biological fluids , antibodies and immunoreagents. Headquartered in St. Louis and founded in 1981, the biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes the raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include human neutrophil elastase, human myeloperoxidase isoform c, alpha fetoprotein, beta 2 microglobulin, and amylase. The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee BioSolutions visit www.LeeBio.com or call 314-968-1091.

Lee BioSolutions Manufactures   Myeloperoxidase  and CRP, Key Prognostic Markers of Inflammation of  Cardiovascular Disease

 ST. LOUIS , MO  Lee BioSolutions Inc, an international manufacturer, producer and supplier of high purity proteins and antigens announces the isolation and increased production of Myeloperoxidase isolated from Leukocytes and C-Reactive Protein from Pleural Fluid.   The St. Louis-based  biotechnology firm has  developed a unique  proprietary process to effectively and efficiently purify  the  Myeloperoxidase and C-Reactive Protein  used in the prediction of Cardiovascular Disease. As a result, Lee is now is a preferred producer for researchers and  diagnostic companies to supply these critical components .

 According to the Centers of Disease and Control, over 40% of all deaths in the United States are attributed to Cardiovascular Disease which means over 1 million of us die every year.  Several risk factors are used by doctors to determine the risk of developing CVC and what better way to access an individual than to test and predict that they will have cardiovascular disease. 

 Lee’s new  Myeloperoxidase and C-Reactive Protein production capabilities enables international diagnostics companies  to quickly manufacture diagnostic tests , which are affordable and easy to administer. Lee has scaled up production to meet global market demand.

 “Lee Biosolutions is on the forefront of Cardiovascular  research  by supplying  highly purified  markers such as C-Reactive Protein and  Myeloperoxidase  .  “ said Burton Lee, President of Lee Biosolutions  . “  You will find the future of clinical diagnostics will utilize a greater number of  combination of biomarkers to predict early clinical diagnosis of diseases as they are identified.”  

 About Lee BioSolutions, Inc.
Lee BioSolutions is an international producer and supplier of high purity finished  human proteins.  Headquartered in St. Louis and founded in 2002, the biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes the raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include Low Denisity Lipoprotein (LDL),High Denisity Lipoprotein (HDL), CkMB and Troponin,  The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee BioSolutions visit www.LeeBio.com or call 314-968-1091.

FOR IMMEDIATE RELEASE

PROTEIN BIOMARKER PRODUCER REVOLUTIONIZES EARLY DETECTION OF GASTRIC STOMACH CANCER

Lee BioSolutions Manufactures Purified Pepsinogen I and II, Key Components in Serum Pepsinogen Tests

ST. LOUIS (November 7th , 2011) Lee BioSolutions, an international manufacturer, producer and supplier of high purity proteins, biological, biochemicals and antibodies   announces a major scientific breakthrough. The St. Louis-based biotechnology firm recently developed a proprietary process to effectively and efficiently purify and stabilize two important gastric cancer protein biomarkers. As a result, Lee is mass producing Pepsinogen I and Pepsinogen II, critical components in serum pepsinogen tests that will revolutionize early detection of stomach and gastric cancer.

According to American Association for Cancer Research (AACR), stomach cancer is the second-leading cause of cancer-related deaths worldwide and the top cause in Eastern Asia, which comprises China, Japan, Taiwan and Korea. Studies have shown that if the disease is detected early, patients five-year survival rates increase 90 percent. Asian and European governments have been advocating mass screenings for decades, but traditional upper endoscopy procedures are painful, invasive and expensive. Lee’s new Pepsinogen I and Pepsinogen II production capabilities enables international diagnostics companies to quickly manufacture serum pepsinogen tests, which are affordable and easy to administer. Lee has scaled up production to meet global market demand.

“Gastric cancer screening using the pepsinogen filter test is the preferred method of cancer detection,” said Burton Lee, president of Lee BioSolutions. “The challenge to-date has been producing large volumes of tests efficiently and affordably. Recently, Lee’s research and development team cracked the code for purifying and stabilizing two very important gastric and stomach cancer protein biomarkers, Pepsinogen I and Pepsinogen II, primary components in serum pepsinogen tests. We now have the expertise, processes and manufacturing capacity to produce enough of these biomaterials to make a significant impact.”

Serum pepsinogen tests for gastric cancer enable healthcare providers to identify high risk patients for further monitoring. Not only do the tests increase survival rates by 90 percent but they also decrease the cost of mass screening programs. Lee currently has clients in Eastern Asia and Europe that plan to produce, distribute and administer the tests.

About Lee BioSolutions, Inc.
Lee BioSolutions is an international producer and supplier of high purity human, animal and recombinant proteins, biological fluids, biochemicals, antibodies and immunoreagents. Headquartered in St. Louis and founded in 1981, the biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes the raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include human neutrophil elastase, human myeloperoxidase isoform c, alpha fetoprotein, beta 2 microglobulin, and amylase. The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee BioSolutions visit www.LeeBio.com or call 314-968-1091.